Chugai Financial Statements From 2010 to 2025

CHGCY Stock  USD 24.89  0.40  1.58%   
Chugai Pharmaceutical financial statements provide useful quarterly and yearly information to potential Chugai Pharmaceutical Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Chugai Pharmaceutical financial statements helps investors assess Chugai Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Chugai Pharmaceutical's valuation are summarized below:
Chugai Pharmaceutical Co does not presently have any fundamental signals for analysis.
Check Chugai Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chugai Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Chugai financial statements analysis is a perfect complement when working with Chugai Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Chugai Pharmaceutical Technical models . Check out the analysis of Chugai Pharmaceutical Correlation against competitors.

Chugai Pharmaceutical Co Company Operating Margin Analysis

Chugai Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Chugai Pharmaceutical Operating Margin

    
  0.42 %  
Most of Chugai Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Chugai Pharmaceutical Co has an Operating Margin of 0.4233%. This is 101.21% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 107.68% lower than that of the firm.

Chugai Pharmaceutical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.
Chugai Pharmaceutical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.68  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chugai Pharmaceutical Co is roughly  1.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chugai Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chugai Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Chugai Pharmaceutical Financial Statements

Chugai Pharmaceutical investors use historical fundamental indicators, such as Chugai Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Chugai Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. CHUGAI PHARMACEUTICAL operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Chugai Pink Sheet Analysis

When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.